RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 121 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,049 | +126.6% | 971,441 | +170.9% | 0.09% | +95.7% |
| Q2 2023 | $463 | +8.2% | 358,626 | +10.6% | 0.05% | +9.5% |
| Q1 2023 | $428 | +199.3% | 324,398 | +240.5% | 0.04% | +133.3% |
| Q4 2022 | $143 | -100.0% | 95,269 | -17.2% | 0.02% | -58.1% |
| Q3 2021 | $418,000 | +660.0% | 115,036 | +617.0% | 0.04% | +377.8% |
| Q1 2021 | $55,000 | -64.5% | 16,043 | -81.0% | 0.01% | -89.5% |
| Q2 2020 | $155,000 | -56.0% | 84,429 | -62.6% | 0.09% | -2.3% |
| Q1 2020 | $352,000 | -33.0% | 225,547 | -8.1% | 0.09% | +44.3% |
| Q4 2019 | $525,000 | +39.6% | 245,487 | +22.1% | 0.06% | +19.6% |
| Q3 2019 | $376,000 | +317.8% | 201,128 | +620.9% | 0.05% | +920.0% |
| Q3 2018 | $90,000 | +73.1% | 27,900 | +110.1% | 0.01% | +25.0% |
| Q1 2014 | $52,000 | – | 13,281 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 4,500,000 | $11,925,000 | 4.90% |
| HealthInvest Partners AB | 1,090,000 | $2,889,000 | 4.07% |
| GREAT POINT PARTNERS LLC | 5,000,000 | $13,250,000 | 2.94% |
| CM Management, LLC | 775,000 | $2,054,000 | 1.55% |
| SECTOR GAMMA AS | 1,469,604 | $3,894,000 | 0.92% |
| Sio Capital Management, LLC | 913,621 | $2,421,000 | 0.73% |
| Telemetry Investments, L.L.C. | 190,000 | $504,000 | 0.65% |
| DAFNA Capital Management LLC | 879,000 | $2,329,000 | 0.59% |
| Rock Springs Capital Management LP | 4,860,200 | $12,880,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $4,074,000 | 0.27% |